Literature DB >> 15259047

The effect of private insurance access on the choice of GP/specialist and public/private provider in Spain.

Marisol Rodríguez1, Alexandrina Stoyanova.   

Abstract

This paper sheds light into the investigation of differential patterns of utilisation of physician services by populations subgroups that is emerging in a number of studies. Using Spanish data from the National Health Survey of 1997 we try to explain the distinct role of the type of insurance on the choice between specialists and GPs and its intertwining with the choice between private and public providers. We estimate a two-stages probit to conclude that differences in insurance access is the main determinant of both, the choice of sector and the kind of physician contacted, giving rise to very different patterns of consumption of GP and specialist visits. People with only public insurance go 2.8 times to the GP per one time that they visit a specialist; individuals with duplicate coverage have a ratio of GP/specialist visits equal to 1.4 (the combination being public GP and private specialist) and people with only private insurance access actually have an 'inverted' pattern of visits: they contact specialists more often than GPs. Age, sex and health and public supply characteristics also have a distinct and interesting impact on these choices. Finally, equity concerns based on the implied assumption that specialists care is superior to general practitioner care are discussed. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15259047     DOI: 10.1002/hec.832

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  19 in total

1.  Voluntary private health insurance among the over 50s in Europe.

Authors:  Omar Paccagnella; Vincenzo Rebba; Guglielmo Weber
Journal:  Health Econ       Date:  2012-02-07       Impact factor: 3.046

2.  [Some causes (and solutions) of the loss of prestige of general practitioners/family doctors. Against the discrediting of heroes].

Authors:  Juan Gérvas; Bárbara Starfield; Sergio Minué; Concepció Violan
Journal:  Aten Primaria       Date:  2007-11       Impact factor: 1.137

3.  [The "glass ceiling" of Spanish primary care].

Authors:  Juan Simó Miñana
Journal:  Aten Primaria       Date:  2009-05-08       Impact factor: 1.137

4.  Inequalities in access to medical care by income in developed countries.

Authors:  Eddy van Doorslaer; Cristina Masseria; Xander Koolman
Journal:  CMAJ       Date:  2006-01-17       Impact factor: 8.262

5.  Health care utilisation and immigration in Spain.

Authors:  José-Ignacio Antón; Rafael Muñoz de Bustillo
Journal:  Eur J Health Econ       Date:  2009-11-07

6.  Health care usage among immigrants and native-born elderly populations in eleven European countries: results from SHARE.

Authors:  Aïda Solé-Auró; Montserrat Guillén; Eileen M Crimmins
Journal:  Eur J Health Econ       Date:  2011-06-10

7.  Inequity in the use of physician services in Norway before and after introducing patient lists in primary care.

Authors:  Astrid L Grasdal; Karin Monstad
Journal:  Int J Equity Health       Date:  2011-06-15

8.  Health-care-seeking patterns in the emerging private sector in Burkina Faso: a population-based study of urban adult residents in Ouagadougou.

Authors:  Idrissa Beogo; Chieh-Yu Liu; Yiing-Jenq Chou; Chuan-Yu Chen; Nicole Huang
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

9.  Difference in patient outcomes coming from public and private hospitals in an intensive care unit in Brazil.

Authors:  Fabio F Amorim; Adriell R Santana; Rodrigo S Biondi; Alethea Pp Amorim; Edmilson B Moura; Karlo J Quadros; Humberto S Oliveira; Rubens Ab Ribeiro
Journal:  J Clin Med Res       Date:  2012-11-11

10.  Socioeconomic patterns in the use of public and private health services and equity in health care.

Authors:  Enrique Regidor; David Martínez; María E Calle; Paloma Astasio; Paloma Ortega; Vicente Domínguez
Journal:  BMC Health Serv Res       Date:  2008-09-14       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.